EQUITY (Tables)

6 Months Ended

Sep. 30, 2020

EQUITY

Summary of allocation of net proceeds

Net proceeds were allocated as the follows:

Warrants	$	3,150,006
Common stock		1,992,118
Total net proceeds	$	5,142,124

Net proceeds were allocated as the follows:

Warrants	$	241,919
Common stock		5,856,378
Total net proceeds	$	6,098,297

Summary of outstanding warrants

The Company has warrants outstanding as follows:

			Weighted		Average
			Average		Remaining
	Warrants	Warrants	Exercise		Contractual
	Outstanding	Exercisable	Price		Life
Balance, March 31, 2019	37,940	37,940	$	4.80	3.96
Granted	2,594,850	2,594,850	$	3.70	4.00
Forfeited	—	—		—	—
Exercised	(1,113,188)	(1,113,188)		—	—
Balance, March 31, 2020	1,519,602	1,519,602	$	1.76	3.21
Granted	568,000	568,000	$	0.63	5.00
Forfeited	(3,132)	(3,132)		—	—
Exercised	(50,000)	(50,000)		—	—
Balance, September 30, 2020 (Unaudited)	2,034,470	2,034,470	$	0.63	3.38

Schedule of fair value of derivative instrument allocated

Fair value of derivative instrument was allocated as the following exercise date:

	Fair  value of derivative  instrument
	allocated to additional paid-in-
Exercised date	capital
August 12, 2019	$	699,523
August 13, 2019		262,108
October 9, 2019		49,122
July 9, 2020		56,662
Total	$	1,067,415